Enveric Biosciences, Inc.
Support and Resistance Levels
Past performance
News About ENVB
All events for ENVB
All deals for ENVB
Financial Ratios
Financial Statements
ENVB vs Sector & Peers
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida. Website enveric.com
Headquarters Cambridge, MA, US